MedTech Solutions S.A. (WSE:MDT)
Poland · Delayed Price · Currency is PLN 0.3400
+0.0040 (1.19%)
At close: Sep 4, 2026
MedTech Solutions Ratios and Metrics
Market cap in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 26 | 19 | 6 | 25 | 16 | 10 | |
Market Cap Growth | 17.24% | 209.43% | -75.52% | 56.04% | 66.29% | 39.47% |
Enterprise Value | 25 | 16 | 7 | 24 | 16 | 21 |
Last Close Price | 0.34 | 0.25 | 0.27 | 1.08 | 0.79 | 0.48 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 3.70 |
PS Ratio | 103.36 | 49.91 | 3.04 | 15.44 | 277.74 | 8.32 |
PB Ratio | 12.80 | 6.95 | -12.06 | 30.02 | 1392.83 | -162.77 |
P/TBV Ratio | 14.36 | 7.65 | - | 37.76 | 1392.83 | - |
P/FCF Ratio | - | - | - | - | - | 20.61 |
P/OCF Ratio | - | - | - | - | - | 20.61 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 101.22 | 42.24 | 3.26 | 14.84 | 278.78 | 18.02 |
EV/EBITDA Ratio | - | - | - | - | 125.36 | - |
EV/FCF Ratio | - | - | - | - | - | 44.68 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | - | - | - | 0.08 | 21.54 | - |
Debt / EBITDA Ratio | - | - | - | - | 1.93 | - |
Net Debt / Equity Ratio | -0.26 | -0.67 | 0.19 | -0.47 | 6.86 | 0.24 |
Net Debt / EBITDA Ratio | 0.19 | 0.58 | 0.08 | 0.60 | 0.62 | 0.01 |
Net Debt / FCF Ratio | 0.13 | 0.44 | 0.09 | 0.38 | -0.20 | -0.03 |
Asset Turnover | 0.09 | 0.16 | 1.95 | 1.96 | 0.20 | 0.25 |
Inventory Turnover | - | 0.55 | 6.58 | - | - | - |
Quick Ratio | 0.96 | 2.51 | 0.48 | 1.42 | 0.74 | 0.69 |
Current Ratio | 2.74 | 3.31 | 0.82 | 2.00 | 0.74 | 0.69 |
Return on Equity (ROE) | -637.28% | -301.48% | -824.44% | -190.48% | - | - |
Return on Assets (ROA) | -65.41% | -87.33% | -72.91% | -52.23% | -51.13% | -18.65% |
Return on Invested Capital (ROIC) | -166.82% | -546.93% | -333.87% | -261.67% | -1554.79% | -28.99% |
Return on Capital Employed (ROCE) | -101.10% | -118.60% | -424.40% | -82.80% | -1851.40% | 2280.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -11.53% | -17.64% | -21.90% | -3.22% | -1.44% | 27.02% |
FCF Yield | -15.52% | -22.07% | -17.38% | -4.18% | -2.47% | 4.85% |
Buyback Yield / Dilution | - | -655.00% | 0.43% | -16.52% | 0.11% | - |